GlassScriptPhysician profile
Beena Shah
NPI 1447279203
$2,666.61
in general payments reported to CMS, 2019-2025
34 companies · $464 in 2025
The $464 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $85.05 · 2021: $427 · 2022: $375 · 2023: $554 · 2024: $487 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418 · Education: $87.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,417.87 |
| Education | $87.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $417.76 | 2021-2025 | Ubrelvy, Qulipta |
| Teva Pharmaceuticals USA, INC. | $413.23 | 2019-2025 | Ajovy, Austedo Xr, Austedo |
| Merck Sharp & Dohme LLC | $308.18 | 2022-2025 | Verquvo, Belsomra |
| Ucb, INC. | $269.29 | 2021-2024 | Briviact |
| Lilly USA, LLC | $191.20 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Amgen INC. | $154.78 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $95.32 | 2023-2025 | Eliquis, Camzyos |
| Lundbeck LLC | $93.80 | 2022-2025 | Vyepti |
| Novartis Pharmaceuticals Corporation | $92.38 | 2019-2025 | |
| Mallinckrodt Enterprises LLC | $69.17 | 2019 | |
| Pfizer INC. | $48.27 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $43.48 | 2019-2022 | |
| Emd Serono, INC. | $42.15 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.47 | 2021 | |
| Mallinckrodt Hospital Products INC. | $37.49 | 2020-2024 | Acthar |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $36.47 | 2021-2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $30.22 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $27.07 | 2021 | |
| Philips North America LLC | $21.91 | 2022 | |
| Inspire Medical Systems, INC. | $21.47 | 2024 | Inspire |
| Eisai INC. | $20.05 | 2022 | |
| Electromed, INC. | $18.22 | 2025 | Smartvest |
| Mdd US Operations, LLC | $16.68 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.51 | 2021 | |
| Biogen, INC. | $16.46 | 2021 | |
| Avion Pharmaceuticals | $16.40 | 2022 | |
| Sk Life Science, INC. | $15.94 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.33 | 2021 | |
| Atricure, INC. | $14.94 | 2022 | |
| Glaxosmithkline, LLC. | $13.69 | 2022 | |
| Acadia Pharmaceuticals INC | $12.96 | 2023 | Nuplazid |
| Livanova USA, INC. | $12.72 | 2021 | |
| Allergan, INC. | $11.42 | 2020 | |
| Amneal Pharmaceuticals LLC | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beena Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.